2Rha SY,Jeung H,Kim Y,et al.Efficacy of gemcitabine as a salvage treatment in breast cancer patients refractory to anthracycline and paclintaxel based regimen[ J].Proc ASC0,2002,21:A2038.
3Nagourney RA.Gemcitabine plus cisplatin in breast cancer[ J ].Oncology(Hunting),2001,15(2 Suppl 3):28-33.
4Nagourney RA,Link JS,Blitzer J,et al.Gemcitabine plus cisplatin repeating doublet therapy in previously treated,relapsed breast cancer patients[ J].J Clin Onco1,2000,15 (11):2245-2249.
5Doroshow J,Tetef M,Margoclin K,et al.Significant activity of gemcitabine(GEM) and cisplatin (DDP) in both heavily (H)and minimally(M)-pretreated metastatic breast cancer (MBC)patients(Pts):A California Cancer Consortium/Loyola Univ.Chicago Trial[ J].Proc ASC0,2000,19:A609H.
2Puiol Tl,Quantin X,Choma.D,et al.Combination che mo ther a py without cisplatin in the treatment ofadvanced non-small cell lung cancer[J].lung cancer,2002,38(suppl3):s57-60.
3Spiellmen.M,Lombart Cusscc,Kallas,et al.single agcnt gemcitabine is active in previously treated metastaic brenst cancer oucology[J].2001,6:303-307.
4Moovsel CJAV,Veeman G,Bergman AM,et al.Combination Che mo ther a py studies with gemcitabine[J].semin oncl,1997,24(17):17.
